D. Salmon

V. Soriano, J. Gervain, M. Mondelli, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Wildo Navegantes de Araújo, M. Ziol, V. Paradis, 2019, AIDS and Behavior.

Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort study

A. d’Arminio Monforte, D. Salmon, A. Cozzi-Lepri, 2016, HIV clinical trials.

Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).

S. Chevret, V. Bourcier, J. Trinchet, 2012, Clinics and research in hepatology and gastroenterology.

Eurosurveillance-View Article

D. Neau, S. Pol, G. Pialoux, 2008 .

A new 3 p 25 locus is associated with liver fibrosis progression in HIV / HCV co-infected patients

F. Dabis, J. Noirel, L. Abel, 2016 .

Clinical and Biological Characteristics of 40 Patients With Neurosyphilis and Evaluation of Treponema pallidum Nested Polymerase Chain Reaction in Cerebrospinal Fluid Samples.

N. Dupin, O. Lortholary, E. Caumes, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy.

D. Salmon, D. Sicard, A. Rigolet, 1998, Scandinavian journal of infectious diseases.

Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).

F. Dabis, M. Carrieri, B. Spire, 2013, Addiction.

Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference.

J. Rockstroh, Y. Benhamou, M. Robain, 2006, Journal of hepatology.

Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy

S. Urien, N. Dupin, D. Salmon, 2008, Antimicrobial Agents and Chemotherapy.

Omeprazole and ranitidine

D. Salmon, 1990 .

HIV infection and COVID-19: risk factors for severe disease

L. Slama, D. Salmon, L. Weiss, 2020, AIDS.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

C. Katlama, D. Neau, P. Morlat, 2018, PLoS ONE.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

C. Katlama, D. Neau, P. Morlat, 2018, PloS one.

Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

F. Vandenesch, A. Péchinot, G. Béraud, 2021, Infection.

Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients

D. Neau, P. Sogni, A. Gervais, 2019, Journal of acquired immune deficiency syndromes.

Claudin‐1 gene variants and susceptibility to hepatitis C infection in HIV‐1 infected intravenous drug users (an ANRS case‐control study)

J. Delfraissy, M. Misrahi, D. Salmon, 2015, Journal of medical virology.

Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study

J. Delfraissy, M. Misrahi, D. Salmon, 2015, PloS one.

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.

F. Tubach, P. Ravaud, X. Mariette, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS.

C. Leport, D. Salmon, J. Vildé, 1991, The Journal of infectious diseases.

Influence of HLA‐C environment on the spontaneous clearance of hepatitis C in European HIV–HCV co‐infected individuals

C. Retière, F. Raffi, A. Cesbron, 2020, Clinical and experimental immunology.

French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers

X. Mariette, D. Salmon, 2003, Annals of the rheumatic diseases.

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

F. Tubach, P. Ravaud, D. Heresbach, 2009, Annals of the rheumatic diseases.

Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.

C. Katlama, D. Costagliola, C. Leport, 2003, AIDS.

Infl uence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy

G. Baron, F. Tubach, P. Ravaud, 2012 .

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

J. Moatti, C. Leport, B. Spire, 2001, AIDS.

Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis.

D. Salmon, G. Pelletier, J. Etienne, 1990, Journal of hepatology.

Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy

R. Tubiana, V. Appay, L. Papagno, 2014, AIDS.

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

V. de Lédinghen, D. Neau, P. Morlat, 2019, PloS one.

A cohort study of enfuvirtide immunological and virological efficacy in clinical practice

M. Pietri, P. Lebon, O. Launay, 2006, Journal of medical virology.

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

C. Katlama, P. Morlat, F. Dabis, 2018, World journal of hepatology.

Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study

F. Carrat, S. Pol, P. Cacoub, 2015, Liver international : official journal of the International Association for the Study of the Liver.

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study

F. Vandenesch, A. Péchinot, G. Béraud, 2022, Advances in Therapy.

Antiretroviral Therapy and Sustained Virological Response to HCV Therapy are Associated with Slower Liver Fibrosis Progression in HIV–HCV-Coinfected Patients: Study from the Anrs Co 13 Hepavih Cohort

F. Dabis, A. Gervais, D. Vittecoq, 2012, Antiviral therapy.

EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

W. Rozenbaum, B. Régnier, C. Leport, 1988, The Lancet.

Incidence, Medical and Socio-Behavioural Predictors of Psychiatric Events in An 11-Year Follow-Up of HIV-Infected Patients on Antiretroviral Therapy

M. Carrieri, C. Protopopescu, C. Leport, 2012, Antiviral therapy.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

M. Ziol, V. de Lédinghen, P. Marcellin, 2017, Gastroenterology.

Resting energy expenditure is increased in stable, malnourished HIV-infected patients.

C. Leport, J. Melchior, F. Vachon, 1991, The American journal of clinical nutrition.

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

F. Gray, D. Salmon, B. Bienvenu, 2005, Acta Neuropathologica.

[Prognosis of spontaneous ascitic infection in cirrhotic patients].

F. Pessione, D. Salmon, G. Pelletier, 1989, Gastroenterologie clinique et biologique.

Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen

C. Rouzioux, L. Mandelbrot, P. Jouannet, 2002, AIDS.

Semen alterations in HIV-1 infected men.

C. Rouzioux, D. Costagliola, L. Mandelbrot, 2002, Human reproduction.

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV‐coinfected patients

D. Neau, P. Morlat, F. Dabis, 2011, Journal of viral hepatitis.

Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy

S. Urien, N. Dupin, A. Lillo-Le Louet, 2005, Antimicrobial Agents and Chemotherapy.

An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.

C. Leport, S. Bastuji‐Garin, D. Salmon, 1989, The Journal of infectious diseases.

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study

M. Dougados, F. Tubach, X. Mariette, 2010, Arthritis research & therapy.

Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy

D. Costagliola, C. Dhiver, M. Mary-Krause, 2006, AIDS.

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

P. Morlat, D. Costagliola, C. Lewden, 2004, International journal of epidemiology.

Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).

F. Raffi, M. Carrieri, C. Protopopescu, 2007, The International journal on drug policy.

Varicella in Patients Infected With the Human Immunodeficiency Virus

M. Lazanas, C. Leport, D. Salmon, 1990 .

Varicella in patients infected with the human immunodeficiency virus.

M. Lazanas, C. Leport, D. Salmon, 1990, Archives of dermatology.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Encrusting cystitis due to Corynebacterium urealyticum in a patient with ANCA-associated vasculitis: case report and review of the literature.

L. Guillevin, A. Bérézné, V. le Guern, 2011, Seminars in arthritis and rheumatism.

Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men.

C. Rouzioux, P. Jouannet, E. Dulioust, 1998, Journal of reproductive immunology.

Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient

D. Bouscary, A. Buzyn, A. Paugam, 2011, Bone Marrow Transplantation.

Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine.

V. Dumaine, F. Larousserie, A. Paugam, 2008, International journal of antimicrobial agents.

First observation in a non-endemic country (Togo) of Penicillium marneffei infection in a human immunodeficiency virus-infected patient: a case report

D. Salmon, B. Saka, W. Halatoko, 2013, BMC Research Notes.

The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

B. Gazzard, A. Mocroft, O. Kirk, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fusarium Endophthalmitis: About a Case of Enucleation

D. Salmon, D. Monnet, D. Slama, 2021, International Journal of Medical Parasitology and Epidemiology Sciences.

Bacterial prostatitis in patients infected with the human immunodeficiency virus.

C. Leport, F. Rousseau, D. Salmon, 1989, The Journal of urology.

[Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)].

P. Morlat, P. Couppié, C. Lewden, 2004, Medecine et maladies infectieuses.

Acute pustular eruption: an unusual clinical feature of disseminated mycobacterial infection in patients with acquired immunodeficiency syndrome.

M. Grossin, D. Salmon, E. Bouvet, 1993, Journal of the American Academy of Dermatology.

[Treatment of Cytomegalovirus infection].

C. Leport, D. Salmon, 1990, La Revue du praticien.

Pneumonia due to Scedosporium apiospermum in a patient with HIV infection.

M. Riquet, F. Le Pimpec-Barthes, D. Dusser, 2000, Scandinavian journal of infectious diseases.

Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines.

D. Salmon, D. Sicard, A. Passeron, 1999 .

Sarcoidosis and HIV infection: influence of highly active antiretroviral therapy.

D. Salmon, D. Sicard, A. Passeron, 1999, The British journal of dermatology.

Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients.

I. Gorin, F. Rousseau, D. Salmon, 1993, The American journal of medicine.

Quantitation of cytomegalovirus (CMV) DNA by real‐time PCR for occurrence of CMV disease in HIV‐infected patients receiving highly active antiretroviral therapy

C. Katlama, D. Costagliola, C. Leport, 2003, Journal of medical virology.

Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients

C. Katlama, D. Costagliola, C. Leport, 2000, AIDS.

T. Cokelaer, G. Gheusi, P. Lledo, 2021, Science Translational Medicine.

Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

D. Costagliola, S. Grabar, C. Pradier, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.

D. Neau, S. Pol, Y. Le Strat, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.

F. Dabis, P. Carrieri, É. Rosenthal, 2011, Vaccine.

Ribavirin and abacavir drug interaction in HIV–HCV coinfected patients: fact or fiction?

J. Izopet, C. Solas, G. Peytavin, 2012, AIDS.

FREQUENCY, LOCALISATIONS AND HISTOLOGICAL DISTRIBUTION OF LYMPHOMAS IN AIDS-PATIENTS BEFORE AND AFTER THE USE OF MULTITHERAPIES

C. Katlama, N. Brousse, M. Tulliez, 1999 .

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

D Emilie, F. Tubach, P. Ravaud, 2009, Arthritis and rheumatism.

Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study

S. Grabar, O. Lortholary, O. Launay, 2008, Journal of acquired immune deficiency syndromes.

Vaccination coverage among social and healthcare workers in ten countries of Samu-social international sites.

F. Ouédraogo, D. Salmon, M. Santantonio, 2017, Vaccine.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Hepatitis E: An emerging infection in high income countries.

J. Izopet, W. Irving, A. Hoepelman, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

P. Morlat, D. Costagliola, G. Chêne, 2014, AIDS.

[HIV infection in intravenous drug addicts].

D. Salmon, D. Sicard, D. Séréni, 1993, La Revue de medecine interne.

Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response

F. Dabis, P. Carrieri, A. Gervais, 2014, AIDS.

Acute pancreatitis related to tigecycline: Case report and review of the literature

V. Dumaine, D. Salmon, L. Eyrolle, 2008, Scandinavian journal of infectious diseases.

É. Oksenhendler, P. Morlat, D. Costagliola, 2015, PloS one.

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus‐coinfected patients

F. Dabis, J. Noirel, L. Abel, 2016, Hepatology.

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

E. van Marck, C. Boshoff, C. Fisher, 1999, Proceedings of the National Academy of Sciences of the United States of America.

D. Salmon, D. Sicard, A. Rigolet, 1999, Postgraduate medical journal.

Utility of the Tétanos Quick Stick® in the vaccine catch-up of adult migrants without proof of prior vaccination.

S. Grabar, N. Vignier, D. Salmon, 2020, Vaccine.

P. Morlat, D. Costagliola, C. Lewden, 2005, Cancer.

[Tuberculous spinal arachnoiditis. Value of intrathecal corticosteroid therapy].

D. Salmon, J. Vildé, F. Bricaire, 1989, Presse medicale.

Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections

V. Dumaine, P. Anract, D. Salmon, 2015, Infection.

Activities of pefloxacin and ciprofloxacin against experimental malaria in mice

J. Pocidalo, D. Salmon, C. Gaudin, 1990, Antimicrobial Agents and Chemotherapy.

[Chronic bone infections after surgery. Treatment with the new quinolones].

C. Leport, B. Godeau, D. Salmon, 1989, Presse medicale.

Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

S. Urien, N. Bouazza, D. Salmon, 2012, British journal of clinical pharmacology.

Influence of the clindamycin-administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic study.

L. Salomon, A. Jannot, B. Heym, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial

L. Cuzin, J. Guillet, B. Silbermann, 2007, PloS one.

Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+ Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy

J. Guillet, M. Sinet, M. Dalod, 1999, Journal of Virology.

Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans.

J. Guillet, O. Launay, M. Surénaud, 2014, Vaccine.

New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.

J. Guillet, G. Pialoux, D. Salmon, 2006, AIDS research and human retroviruses.

Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults

Y. Lévy, J. Guillet, O. Launay, 2006, AIDS.

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men

Roland Tubiana, Franck Letourneur, Christine Katlama, 2004, AIDS.

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

P. Morlat, D. Costagliola, C. Lewden, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute hepatitis C virus infection.

C. Boucher, W. Irving, D. Salmon, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).

P. Morlat, D. Costagliola, C. Lewden, 2010, International journal of epidemiology.

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

R. Salamon, F. Brun-Vézinet, C. Katlama, 2017, The Journal of antimicrobial chemotherapy.

Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants

P. Morlat, P. Sogni, K. Lacombe, 2021, HIV medicine.

The Incidence of AIDS-De fi ning Illnesses at a Current CD 4 Count ≥ 200 Cells / μ L in the Post – Combination Antiretroviral Therapy Era

B. Gazzard, A. Mocroft, O. Kirk, 2013 .

HCV or HBV coinfection and lymphoma risk in people living with HIV.

C. Katlama, D. Costagliola, N. Mounier, 2019, AIDS (London).

HCV or HBV coinfection and lymphoma risk in people living with HIV.

C. Katlama, D. Costagliola, N. Mounier, 2019, AIDS.

P. Morlat, D. Costagliola, C. Lewden, 2004 .

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.

D. Neau, P. Morlat, F. Dabis, 2017, Journal of hepatology.

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019

J. Lazarus, M. Hellard, M. van der Valk, 2022, EClinicalMedicine.

Trends in survival after cancer diagnosis among HIV‐infected individuals between 1992 and 2009. Results from the FHDH‐ANRS CO4 cohort

D. Costagliola, S. Grabar, J. Spano, 2015, International journal of cancer.

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.

V. de Lédinghen, V. Paradis, B. Autran, 2020, Journal of hepatology.

A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients

N. Dupin, O. Lortholary, O. Launay, 2009, Antiviral therapy.

A familial aggregate of common variable immunodeficiency, Hodgkin disease and other malignancies in Newfoundland--I. Clinical features.

M. Landre, G. Fraser, D. Salmon, 1979, Clinical and investigative medicine. Medecine clinique et experimentale.

Factors associated with guideline‐based hepatitis C virus (HCV) treatment initiation in HIV/HCV‐coinfected patients: role of comorbidities and physicians' perceptions

D. Neau, P. Morlat, F. Dabis, 2013, HIV medicine.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.

D. Neau, P. Morlat, F. Dabis, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1‐coinfected patients

J. Rockstroh, F. Dabis, P. Sogni, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals

D. Costagliola, C. Pradier, D. Salmon, 2005, Antiviral therapy.

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.

C. Katlama, J. Capeau, F. Raffi, 2019, Diabetes & metabolism.

Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France

P. Morlat, D. Costagliola, C. Lewden, 2005, Scandinavian journal of infectious diseases.

Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum

D. Salmon, J. Vildé, B. Andrieu, 1986, Infection and immunity.

Targeted HIV Screening in Eight Emergency Departments: The DICI‐VIH Cluster‐Randomized Two‐Period Crossover Trial

G. Verbeke, I. Durand-zaleski, G. Hejblum, 2017, Annals of emergency medicine.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in HIV-infected patients.

D. Salmon, G. Grateau, D. Sicard, 1995, AIDS.

Current knowledge and future perspectives on acute hepatitis C infection.

P. Klenerman, A. Wensing, J. Rockstroh, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Dao Sen Wang, M. Poljak, F. Ceccherini‐Silberstein, 2022, JHEP reports : innovation in hepatology.

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non‐invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration

V. Paradis, F. Dabis, F. Degos, 2014, HIV medicine.

Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy

M. Humbert, G. Baron, P. Ravaud, 2007, Annals of the rheumatic diseases.

[Left vocal cord paralysis in cytomegalovirus multifocal neuropathy in a patient with HIV infection].

D. Salmon, D. Sicard, A. de la Blanchardière, 1996, Presse medicale.

Number of deaths among HIV-infected adults in France in 2000, three-source capture–recapture estimation

P. Morlat, D. Costagliola, C. Lewden, 2006, Epidemiology and Infection.

Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS.

A. Brézin, D. Salmon, P. Blanche, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Emergence of HIV-1 mutated strains after interruption of highly active antiretroviral therapy in chronically infected patients

W. Rozenbaum, S. Grabar, G. Pialoux, 2003, AIDS.

Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.

C. Fagard, C. Rouzioux, F. Raffi, 2016, The Journal of antimicrobial chemotherapy.

Current knowledge and future perspectives on acute hepatitis C 1

P. Klenerman, A. Wensing, Håkan, 2022 .

Use of well-defined HIV-derived epitopes to evaluate CD4(+) and CD8(+) T cell responses in patients with chronic HIV-1 infection treated with HAART.

W. Rozenbaum, S. Grabar, J. Guillet, 2004, AIDS research and human retroviruses.

A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.

V. de Lédinghen, S. Bertrais, R. Anty, 2017, Journal of hepatology.

Sarcoidosis in a patient with acquired immunodeficiency syndrome treated with interleukin-2.

D. Salmon, D. Sicard, F. Rollot, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study

A. Jannot, D. Salmon, V. Jullien, 2022, Antibiotics.

[Toxoplasma gondii pneumopathy in a patient with the acquired immunodeficiency syndrome: demonstration of the parasite by bronchioloalveolar lavage].

J. Touboul, P. Fouret, J. Fermand, 1986, Revue de Pneumologie Clinique.

Atazanavir crystal nephropathy.

M. Daudon, H. Izzedine, D. Salmon, 2007, AIDS.

COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system

T. Cokelaer, G. Gheusi, P. Lledo, 2020, bioRxiv.

Characteristics and response to antiretroviral therapy of HIV‐1‐infected patients born in Africa and living in France

R. Salamon, F. Brun-Vézinet, C. Leport, 2007, HIV medicine.

Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012).

C. Rouzioux, P. Jouannet, B. Silbermann, 2002, AIDS.

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

M. Lê, G. Peytavin, O. Launay, 2017, The Journal of antimicrobial chemotherapy.

Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.

C. Katlama, D. Neau, P. Morlat, 2019, European journal of gastroenterology & hepatology.

Factors associated with release relief of Long COVID symptoms at 12-Months and their impact on daily life

D. Salmon, P. Oustric, D. Slama, 2022, medRxiv.

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C

G. Hunault, F. Oberti, P. Calès, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.

France Mentré, Xavier Duval, F. Mentré, 2008, British journal of clinical pharmacology.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Increase in double‐positive CD4+CD8+ peripheral T‐cell subsets in an HIV‐infected patient

F. Kostolanský, V. Ribrag, F. Picard, 1993, AIDS.

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries

F. Negro, J. Gervain, A. Duberg, 2018, Antiviral research.

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.

M. Hellard, M. van der Valk, A. Rauch, 2023, The Lancet. Public health.

P643 Causes of liver related death in HIV-infected patients in France: mortality 2005 Survey

P. Morlat, D. Costagliola, C. Lewden, 2007 .

S. Urien, N. Dupin, H. Chappuy, 2005, British Journal of Clinical Pharmacology.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study

W. Rozenbaum, J. Guillet, G. Pialoux, 2008, Clinical and Vaccine Immunology.

Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV

E. Lanoy, D. Costagliola, S. Grabar, 2023 .

Endocarditis due to Pasteurella multocida with glomerulonephritis.

B. Fantin, D. Salmon, J. Vildé, 1989, The American journal of medicine.

A familial aggregate of common variable immunodeficiency, Hodgkin disease and other malignancies in Newfoundland--II. Genealogical analysis and conclusions regarding hereditary determinants.

M. Landre, G. Fraser, D. Salmon, 1979, Clinical and investigative medicine. Medecine clinique et experimentale.

[Contribution of air mycological control for the prevention of invasive nosocomial aspergillosis].

J. Dupouy-Camet, A. Paugam, D. Salmon, 1997, Pathologie-biologie.

Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.

A. Maignan, Y. Yazdanpanah, D. Neau, 2021, The Journal of infectious diseases.

Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system

J. Le bras, D. Salmon, J. Vildé, 1990, Antimicrobial Agents and Chemotherapy.

Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system

J. Le bras, D. Salmon, J. Vildé, 1988, Infection and immunity.

Trimethoprim-sulphamethoxazole desensitization in HIV-infected patients: an open study.

D. Salmon, G. Hazebroucq, D. Sicard, 1995, AIDS.

Ribavirin and abacavir drug interaction in HIV–HCV coinfected patients: fact or fiction?

J. Izopet, C. Solas, G. Peytavin, 2012, AIDS.

Influence of HLA‐C environment on the spontaneous clearance of hepatitis C in European HIV–HCV co‐infected individuals

C. Retière, F. Raffi, A. Cesbron, 2020, Clinical and experimental immunology.

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

F. Dabis, M. Carrieri, B. Spire, 2014, Journal of hepatology.

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

Potentiation ofChloroquine Activity against Plasmodium falciparum bythePeroxidase-Hydrogen

D. Salmon, K. Malhotra, 1990 .

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1‐coinfected patients

J. Rockstroh, F. Dabis, P. Sogni, 2015, Liver international : official journal of the International Association for the Study of the Liver.

[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment].

P. Morlat, D. Costagliola, C. Lewden, 2004, Presse medicale.

Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study

F. Carrat, S. Pol, P. Cacoub, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

C. Katlama, M. Shoai, H. Melliez, 2018, The Journal of antimicrobial chemotherapy.